Epidemiology and Dynamics of Development
The development of retinal damage correlates directly with the duration of diabetes mellitus. It is a classic late complication that requires time for structural vascular changes to form. Statistics clearly demonstrate this relationship:
- At disease onset: signs of fundus pathology are detected in only a small fraction of patients—about 3%.
- After 10 years: as metabolic disorders progress, pathological changes are documented in 40–45% of patients.
- After 15 years: specific retinal damage is diagnosed in nearly every patient—97% of cases.
Understanding this chronology is critical for clinical practice as it highlights the latent accumulation of microvascular defects and dictates the need for regular screening.
Key Pathogenetic Mechanisms
The formation of diabetic ocular damage is driven by two fundamental pathophysiological processes:
- Microangiopathy. This acts as the initiating factor. There is systemic damage to small blood vessels, primarily arterioles supplying the ocular tissues and optic nerve structures.
- Hypoxia. Due to impaired blood supply, ocular tissues (especially the retina) experience severe oxygen deprivation.
It is this escalating oxygen deficit that triggers a cascade of compensatory, yet ultimately destructive, reactions leading to severe anatomical defects.
Non-Proliferative (Background) Stage
There are two main forms of the disease. The first is non-proliferative retinopathy (also called background or simple). This is the most common variant, accounting for over 90% of all diagnosed cases.
Pathogenesis at this stage involves a sequential chain of microvascular events:
- Initially, microvascular wall permeability pathologically increases.
- The liquid portion of blood leaks into the tissues, leading to the formation of exudates.
- Arteriolar and venular walls lose their elasticity, forming specific outpouchings called microaneurysms.
- Microthrombi form within the lumens of damaged capillaries, inevitably resulting in vascular occlusion.
- Due to vascular fragility, microhemorrhages occur in the retinal tissue and vitreous body.
Capillary occlusion by microthrombi exacerbates local ischemia, completing the vicious cycle of pathogenesis. It is at this stage that a serious risk of vision loss begins to develop.
Proliferative Stage
The second form is proliferative retinopathy. It is significantly less common, occurring in about 10% of patients, but features an extremely severe clinical course. This stage is the direct evolutionary continuation of the non-proliferative stage when adaptive reserves are exhausted.
The key sign is neovascularization—the pathological formation of new microvessels. This mechanism is actively stimulated by tissue hypoxia: the retina, attempting to compensate for oxygen deprivation, initiates the growth of new capillaries. However, these vessels are morphologically abnormal and grow directly into the vitreous body.
In areas of massive hemorrhage from these fragile vessels, connective tissue proliferation begins, leading to the formation of dense scars. The final and most dramatic point of this cascade is retinal detachment, which occurs in areas of major hemorrhages and scarring, leading to permanent vision loss.